Bioscience Animal Health Public Company Limited

SET:BIS Stock Report

Market Cap: ฿1.0b

Bioscience Animal Health Past Earnings Performance

Past criteria checks 1/6

Bioscience Animal Health's earnings have been declining at an average annual rate of -0.8%, while the Healthcare industry saw earnings growing at 20.9% annually. Revenues have been growing at an average rate of 9.7% per year. Bioscience Animal Health's return on equity is 6.7%, and it has net margins of 2.1%.

Key information

-0.8%

Earnings growth rate

-16.6%

EPS growth rate

Healthcare Industry Growth23.6%
Revenue growth rate9.7%
Return on equity6.7%
Net Margin2.1%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Bioscience Animal Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SET:BIS Revenue, expenses and earnings (THB Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 232,426512790
30 Sep 232,346482640
30 Jun 232,287452650
31 Mar 232,215452620
31 Dec 222,213562600
30 Sep 222,181602750
30 Jun 222,095662710
31 Mar 222,091772680
31 Dec 211,986722620
30 Sep 211,911752500
31 Dec 201,782622620
31 Dec 191,881302450

Quality Earnings: BIS has high quality earnings.

Growing Profit Margin: BIS's current net profit margins (2.1%) are lower than last year (2.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BIS's earnings have declined by 0.8% per year over the past 5 years.

Accelerating Growth: BIS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: BIS had negative earnings growth (-9.3%) over the past year, making it difficult to compare to the Healthcare industry average (-29.6%).


Return on Equity

High ROE: BIS's Return on Equity (6.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.